Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

DM and AA may share a common cause.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Skin color may change how alopecia areata looks under a dermoscope.